Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Iron Chelation
Interventions: DRUG: Ketotifen 1 MG
Sponsor: Horus University